Piperine improves levodopa availability in the 6‐OHDA ‐lesioned rat model of Parkinson's disease by suppressing gut bacterial tyrosine decarboxylase
CNS Neuroscience & Therapeutics · 2024-02 · 30 (2)
DOI: 10.1111/cns.14383 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 01.08.2023. Verfasst von Xiaolu Hu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Lab of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome, Alkaloids, Piperidines. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
Tyrosine decarboxylase (TDC) presented in the gut‐associated strain Enterococcus faecalis can convert levodopa (L‐dopa) into dopamine (DA), and its increased abundance would potentially minimize the availability and efficacy of L‐dopa. However, the known human decarboxylase inhibitors are ineffective in this bacteria‐mediated conversion. This study aims to investigate the inhibition of piperine (PIP) on L‐dopa bacterial metabolism and evaluates the synergistic effect of PIP combined with L‐dopa on Parkinson's disease (PD).
Methods
Metagenomics sequencing was adopted to determine the regulation of PIP on rat intestinal microbiota structure, especially on the relative abundance of E. faecalis . Then, the inhibitory effects of PIP on L‐dopa conversion and TDC expression of E. faecalis were tested in vitro. We examined the synergetic effect of the combination of L‐dopa and PIP on 6‐hydroxydopamine (6‐OHDA)‐lesioned rats and tested the regulations of L‐dopa bioavailability and brain DA level by pharmacokinetics study and MALDI‐MS imaging. Finally, we evaluated the microbiota‐dependent improvement effect of PIP on L‐dopa availability using pseudo‐germ‐free and E. faecalis ‐transplanted rats.
Results
We found that PIP combined with L‐dopa could better ameliorate the move disorders of 6‐OHDA‐lesioned rats by remarkably improving L‐dopa availability and brain DA level than L‐dopa alone, which was associated with the effect of PIP on suppressing the bacterial decarboxylation of L‐dopa via effectively downregulating the abnormal high abundances of E. faecalis and TDC in 6‐OHDA‐lesioned rats.
Conclusion
Oral administration of L‐dopa combined with PIP can improve L‐dopa availability and brain DA level in 6‐OHDA‐lesioned rats by suppressing intestinal bacterial TDC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Lab of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
- Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, China.
- School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
- Core facilities of modern pharmaceuticals, Capital Medical University, Beijing, China.
ORCID-Profile: Xia Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hu, X., Yu, L., Li, Y., Li, X., Zhao, Y., Xiong, L., Ai, J., Chen, Q., Wang, X., Chen, X., Ba, Y., Wang, Y., & Wu, X. (2024). Piperine improves levodopa availability in the 6‐OHDA ‐lesioned rat model of Parkinson's disease by suppressing gut bacterial tyrosine decarboxylase. CNS Neuroscience & Therapeutics, 30(2). https://doi.org/10.1111/cns.14383
Vancouver
Hu X, Yu L, Li Y, Li X, Zhao Y, Xiong L, et al. Piperine improves levodopa availability in the 6‐OHDA ‐lesioned rat model of Parkinson's disease by suppressing gut bacterial tyrosine decarboxylase. CNS Neuroscience & Therapeutics. 2024;30(2). doi:10.1111/cns.14383
BibTeX
@article{Hu2024,
author = {Hu, Xiaolu and Yu, Lan and Li, Yatong and Li, Xiaoxi and Zhao, Yimeng and Xiong, Lijuan and Ai, Jiaxuan and Chen, Qijun and Wang, Xing and Chen, Xiaoqing and Ba, Yinying and Wang, Yaonan and Wu, Xia},
title = {Piperine improves levodopa availability in the 6‐OHDA ‐lesioned rat model of Parkinson's disease by suppressing gut bacterial tyrosine decarboxylase},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {2},
doi = {10.1111/cns.14383}
}
EUVIMED